Themis Medicare’s Haridwar Plant gets EU-GMP certification

23 Aug 2018 Evaluate

Themis Medicare’s Haridwar Plant has been granted a Certificate by European Union - Good Manufacturing Practice (EU-GMP) for company’s oral and topical manufacturing sections. With this, the company can commercialise its products in the European Union (EU) countries.

This certification will also give access to the company to commercialise its products in the Pharmaceutical Inspection Co-operation Scheme (PICS) markets for company’s products manufactured at company’s State of-the-Art manufacturing facility at Haridwar.

Themis Medicare is engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs) and Formulations. The company is also engaged in supplying their research formulations to well-known Pharmaceutical companies in India namely Alkem Lab, Fulford, Intas Pharmaceuticals, IPCA Lab., Cadila Healthcare, Aristo Pharma, Mankind Pharma, Shreya Lifesciences, Nicholas Piramal, Unichem Lab, etc.

Themis Medicare Share Price

105.60 -0.70 (-0.66%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×